Position in JNJ
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$1,423,501
-$1,899,171 QoQ
Shares Held
5,605
-58.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#2,654
of 4,676 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Persistent Asset Partners Ltd holds $4,144,035 across 7 Drug Manufacturers - General names. JNJ ranks #1 (34.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
5,605 | $1,423,501 | |
| 2 | NVO |
Novo Nordisk A S
|
25,600 | $1,227,264 | |
| 3 | AZN |
Astrazeneca PLC
|
4,058 | $769,477 | |
| 4 | SNY |
Sanofi
|
14,750 | $629,235 | |
| 5 | LLY |
ELI LILLY & Co
|
56 | $67,168 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
194 | $24,509 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
50 | $2,881 |
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,423,501 | 5,605 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,322,672 | 13,593 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $3,664,670 | 17,708 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||